Azora Therapeutics, Inc. (DE) AZR
NASDAQ AZR
$4.09 +0.35 (+9.36%)
At close: Nov 13, 2026 · 4:00 PM EST

Azora Therapeutics, Inc. (DE) (AZR) Return on Equity [ROE] (2018 - 2026)

Updated

Azora Therapeutics, Inc. (DE) (AZR) reported Return on Equity [ROE] of -163.92% for Q1 2026, up 125.16 percentage points from -289.08% a year earlier but down 7.53 percentage points from the prior quarter.

Analysis

Azora Therapeutics, Inc. (DE) (AZR) Return on Equity [ROE] (2018 - 2026) Analysis & Trends

For FY2025, Azora Therapeutics, Inc. (DE) posted Return on Equity [ROE] of -163.72%, up 160.08 percentage points from FY2024.

  • Return on Equity [ROE] has a five-year change of +32.08 percentage points (FY2020 to FY2025).
  • By year, Return on Equity [ROE] came in at -323.80% in FY2024 (-184.58 pp), -139.22% in FY2023 (+236.10 pp), -375.32% in FY2022 (+143.06 pp) and -518.38% in FY2021 (-322.58 pp).
  • Five-year quarterly Return on Equity [ROE] spans a low of -539.80% in Q1 2023 and a high of -156.05% in Q3 2025.
  • Year over year, Return on Equity [ROE] has now increased in each of the last four quarters, with an average year-over-year change of +22.42 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Equity [ROE] in five years was Q1 2024 (a gain of 369.41 percentage points); the low point was Q1 2023 (a drop of 292.30 percentage points).
  • Per Business Quant data, the three quarters before Q1 2026 came in at -156.39% (Q4 2025), -156.05% (Q3 2025) and -216.50% (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 19.33%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 5.63%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 21.60%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 72.13%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -31.17%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 4.66%
10 Azora Therapeutics, Inc. (DE) 58.43 Mn -2.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -163.92%
Dec 31, 2025 -156.39%
Sep 30, 2025 -156.06%
Jun 30, 2025 -216.50%
Mar 31, 2025 -289.08%
Dec 31, 2024 -265.23%
Sep 30, 2024 -256.82%
Jun 30, 2024 -235.42%
Mar 31, 2024 -170.39%
Dec 31, 2023 -159.54%
Sep 30, 2023 -214.61%
Jun 30, 2023 -327.69%
Mar 31, 2023 -539.80%
Dec 31, 2022 -293.16%
Sep 30, 2022 -236.19%
Jun 30, 2022 -182.10%
Mar 31, 2022 -247.50%
Dec 31, 2021 -364.54%
Sep 30, 2021 -283.67%
Jun 30, 2021 -307.85%
API Access

Azora Therapeutics, Inc. (DE) Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AZR&period=max&api_key=YOUR_API_KEY